Allogeneic	O
injection	O
of	O
fetal	B-Cell
membrane	I-Cell
-	I-Cell
derived	I-Cell
mesenchymal	I-Cell
stem	I-Cell
cells	I-Cell
induces	O
therapeutic	O
angiogenesis	O
in	O
a	O
rat	O
model	O
of	O
hind	B-Organism_subdivision
limb	I-Organism_subdivision
ischemia	O
.	O

Bone	B-Cell
marrow	I-Cell
-	I-Cell
derived	I-Cell
mesenchymal	I-Cell
stem	I-Cell
cells	I-Cell
(	O
BM	B-Cell
-	I-Cell
MSC	I-Cell
)	O
have	O
been	O
demonstrated	O
to	O
be	O
an	O
attractive	O
therapeutic	O
cell	B-Cell
source	O
for	O
tissue	B-Tissue
regeneration	O
and	O
repair	O
.	O

However	O
,	O
it	O
remains	O
unknown	O
whether	O
or	O
not	O
allogeneic	O
transplantation	O
of	O
mesenchymal	B-Cell
stem	I-Cell
cells	I-Cell
(	O
MSC	B-Cell
)	O
derived	O
from	O
fetal	B-Multi-tissue_structure
membranes	I-Multi-tissue_structure
(	O
FM	B-Multi-tissue_structure
)	O
,	O
which	O
are	O
generally	O
discarded	O
as	O
medical	O
waste	O
after	O
delivery	O
,	O
has	O
therapeutic	O
potential	O
.	O

FM	B-Cell
-	I-Cell
MSC	I-Cell
were	O
obtained	O
from	O
Lewis	O
rats	O
and	O
had	O
surface	B-Cellular_component
antigen	O
expression	O
and	O
multipotent	O
potential	O
partly	O
similar	O
to	O
those	O
of	O
BM	B-Cell
-	I-Cell
MSC	I-Cell
.	O

Compared	O
with	O
BM	B-Cell
-	I-Cell
MSC	I-Cell
,	O
FM	B-Cell
-	I-Cell
MSC	I-Cell
secreted	O
a	O
comparable	O
amount	O
of	O
hepatocyte	O
growth	O
factor	O
despite	O
a	O
small	O
amount	O
of	O
vascular	O
endothelial	O
growth	O
factor	O
.	O

FM	B-Cell
-	I-Cell
MSC	I-Cell
and	O
BM	B-Cell
-	I-Cell
MSC	I-Cell
both	O
expressed	O
major	O
histocompatibility	O
complex	O
(	O
MHC	O
)	O
class	O
I	O
but	O
not	O
MHC	O
class	O
II	O
antigens	O
and	O
did	O
not	O
elicit	O
allogeneic	O
lymphocyte	B-Cell
proliferation	O
in	O
mixed	O
lymphocyte	B-Cell
culture	I-Cell
.	O

FM	B-Cell
-	I-Cell
MSC	I-Cell
or	O
BM	B-Cell
-	I-Cell
MSC	I-Cell
obtained	O
from	O
Lewis	O
rats	O
were	O
injected	O
into	O
a	O
MHC	O
-	O
mismatched	O
August	O
-	O
Copenhagen	O
-	O
Irish	O
rat	O
model	O
of	O
hind	B-Organism_subdivision
limb	I-Organism_subdivision
ischemia	O
.	O

Three	O
weeks	O
after	O
injection	O
,	O
blood	B-Organism_substance
perfusion	O
and	O
capillary	B-Tissue
density	O
were	O
significantly	O
higher	O
in	O
the	O
FM	B-Cell
-	I-Cell
MSC	I-Cell
and	O
BM	B-Cell
-	I-Cell
MSC	I-Cell
groups	O
than	O
in	O
the	O
phosphate	O
-	O
buffered	O
saline	O
group	O
,	O
and	O
allogeneic	O
FM	B-Cell
-	I-Cell
MSC	I-Cell
and	O
BM	B-Cell
-	I-Cell
MSC	I-Cell
were	O
still	O
observed	O
.	O

In	O
nonischemic	O
hind	B-Tissue
limb	I-Tissue
tissues	I-Tissue
,	O
allogeneic	O
FM	B-Cell
-	I-Cell
MSC	I-Cell
and	O
BM	B-Cell
-	I-Cell
MSC	I-Cell
injection	O
were	O
associated	O
with	O
a	O
comparatively	O
small	O
amount	O
of	O
T	B-Cell
lymphocyte	I-Cell
infiltration	O
,	O
compared	O
with	O
the	O
injection	O
of	O
allogeneic	O
splenic	B-Cell
lymphocytes	I-Cell
.	O

In	O
conclusion	O
,	O
allogeneic	O
FM	B-Cell
-	I-Cell
MSC	I-Cell
injection	O
did	O
not	O
elicit	O
a	O
lymphocyte	B-Cell
proliferative	O
response	O
and	O
provided	O
significant	O
improvement	O
in	O
a	O
rat	O
model	O
of	O
hind	B-Organism_subdivision
limb	I-Organism_subdivision
ischemia	O
,	O
comparable	O
to	O
the	O
response	O
to	O
BM	B-Cell
-	I-Cell
MSC	I-Cell
.	O

Thus	O
,	O
allogeneic	O
injection	O
of	O
FM	B-Cell
-	I-Cell
MSC	I-Cell
may	O
be	O
a	O
new	O
therapeutic	O
strategy	O
for	O
the	O
treatment	O
of	O
severe	O
peripheral	B-Multi-tissue_structure
vascular	I-Multi-tissue_structure
disease	O
.	O

Disclosure	O
of	O
potential	O
conflicts	O
of	O
interest	O
is	O
found	O
at	O
the	O
end	O
of	O
this	O
article	O
.	O

